Clinical Trial Update: Evaluation of EXPAREL for Prolonged Postsurgical Analgesia in Subjects Undergoing Third Molar Extraction [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating EXPAREL for prolonged postoperative analgesia in third molar extraction was completed with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dental Pain

Drugs mentioned

• Exparel (liposomal bupivacaine)

Snippet

Sponsor: Pacira Pharmaceuticals, Inc | Conditions: Dental Pain | Phase 3 | Status: COMPLETED | Results posted: 2020-12-10